NewswireToday - /newswire/ -
Wayne, PA, United States, 2007/03/16 - Octagon’s Patrick Thomas, associate director of Regulatory Affairs, will be the host of a Webinar presentation entitled, “The Global eCTD Guidance Interpretation: What’s in it for you?”.
Jim Walker, chairman and CEO of Octagon Research Solutions, Inc., a pioneer and leader in the electronic transformation of clinical R&D in the life sciences industry, announced today that Octagon’s Patrick Thomas, associate director of Regulatory Affairs, will be the host of a free Webinar presentation entitled, “The Global eCTD Guidance Interpretation: What’s in it for you?”.
A critical component in defining an organization’s approach to eCTD is the development of an eCTD Guidance Interpretation that contains the organization’s strategy and details the relevant standards of practice that support the creation of compliant eCTD submissions. During this Webinar, Octagon will discuss its new Global eCTD Guidance Interpretation offering. This offering includes detailed documentation of standards and practices and is the result of over 500 hours of expert effort spanning 42 different guidance documents and specifications.
About Octagon’s Patrick Thomas
Patrick Thomas has 10 years of pharmaceutical experience. In his current position, Mr. Thomas is a regulatory consultant in the pharmaceutical/biotechnology industry, specializing in electronic submissions and initiatives such as eCTD and SPL. While at Octagon, Mr. Thomas has worked on numerous IND, NDA, BLA and ANDA applications, both in traditional and CTD/eCTD format. Prior to joining Octagon, Mr. Thomas was a Program Manager in the U.S. Regulatory Affairs Group at GlaxoSmithKline. Mr. Thomas received a B.S. degree in Biology from The Pennsylvania State University and an M.S. degree in Quality Assurance/Regulatory Affairs from Temple University.
About Octagon Research Solutions, Inc.
Octagon is a pioneer and leading process-centric solutions provider that offers a suite of regulatory, clinical, process, and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. We leverage the power of electronic submissions through deep domain knowledge, cross-functional electronic submission expertise, a holistic process approach, and integrated solutions. Octagon is headquartered in Wayne, PA, with European headquarters in Amersham, UK.